Latest Breaking News On - Annovis bio - Page 1 : comparemela.com

Intellia Up on Upbeat Long-Term Angioedema Study Data - Annovis Bio (NYSE:ANVS), ALX Oncology Holdings (NASDAQ:ALXO)

Intellia Therapeutics' (NASDAQ: NTLA) shares gained 10% on Jun 3 after the company reported encouraging long-term data from the phase I portion of its early to mid-stage study evaluating NTLA-2002 for treating hereditary angioedema.

Annovis-bio
Intellia-therapeutics-inc
Oncology-holdings
Intellia-therapeutics
Zacks-rank
Zacks-consensus-estimate

AbbVie Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU - AbbVie (NYSE:ABBV), ALX Oncology Holdings (NASDAQ:ALXO)

AbbVie (NYSE: ABBV) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending approval of Skyrizi (risankizumab) in the EU to treat adults with moderately to severely active ulcerative colitis (UC).

United-states
Abbvie-skyrizi
Annovis-bio
Boehringer-ingelheim
Abbvie-inc
Committee-for-medicinal-products-human-use
Entera-bio-ltd
European-medicines-agency
Oncology-holdings
Medicinal-products
Human-use
Zacks-rank

12 Health Care Stocks Moving In Friday's Intraday Session - Anebulo Pharmaceuticals (NASDAQ:ANEB), Annovis Bio (NYSE:ANVS)

12 Health Care Stocks Moving In Friday's Intraday Session - Anebulo Pharmaceuticals (NASDAQ:ANEB), Annovis Bio (NYSE:ANVS)
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Calidi-biotherapeutics
Annovis-bio
Anebulo-pharmaceuticals

Buntanetap helps subgroup of mild Alzheimer's patients, data show

Buntanetap helps subgroup of mild Alzheimer's patients, data show
alzheimersnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from alzheimersnewstoday.com Daily Mail and Mail on Sunday newspapers.

Hawaii
United-states
Philadelphia
Pennsylvania
Annovis-bio
Cheng-fang
Melissa-gaines
Drug-administration
University-of-hawaii
Alzheimer-association-international-conference
Association-international-conference
Mini-mental-state-examination

Annovis Announces New Publication in a Peer-Reviewed Journal

MALVERN, Pa., May 21, 2024 Annovis Bio, Inc. , a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, announced the publication of a new article.

Malvern
Pennsylvania
United-states
Posiphen-pharmacokinetics
Annovis-bio
Maria-maccecchini
Annovis-bio-inc
Securities-exchange
Company-annual-report-on-form
Twitter
Linkedin
Special-issue